在接受《新科学家》杂志采访时,理查德·埃布林认为:40年前,亚利桑那大学的免疫及病理学教授理查德·埃布林(Richard Ablin,上图)发现了前列腺特异性抗原(PSA)后,与他人共同撰写了《巨大的前列腺骗局:医疗巨头如何绑架PSA并引起健康灾难》,认为PSA不应被作为一种面向所有男性的癌症筛查工具。问:您在书中批评了将前列腺特异性抗原(PSA)作为癌症筛查的行为,您是怎么想的?答:我想揭露泌尿外科协会和药厂对于PAS的不正当使用,他们将金钱置于病人的利益之上。还想告诉大家,美国食品药品监督局(FDA)是如何对 In an interview with New Scientist magazine, Richard Epping: 40 years ago, Richard Ablin, a professor of immunology and pathology at the University of Arizona, found prostate-specific Antigen (PSA), co-authored “The Great Prostate Panic: How Medical Giants Abducted PSA and Could Cause Health Disaster,” arguing that PSA should not be used as a cancer screening tool for all men. Q: How do you think about the behavior of using prostate-specific antigen (PSA) as a cancer screening in your book? A: I would like to expose the improper use of PAS by urological associations and pharmaceutical companies. They put money Placed on the patient’s benefit. I also want to tell you how the FDA is doing